Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.

Clinical neuroradiology - 1 Sept 2019

Hempel Johann-Martin, Schittenhelm Jens, Klose Uwe, Bender Benjamin, Bier Georg, Skardelly Marco, Tabatabai Ghazaleh, Castaneda Vega Salvador, Ernemann Ulrike, Brendle Cornelia

Abstract excerpt

PURPOSE: To assess the diagnostic performance of dynamic susceptibility contrast perfusion magnetic resonance perfusion imaging (DSC-MRI) for in vivo human glioma molecular profiling. METHODS: In this study 100 patients with histopathologically confirmed glioma who provided written informed consent were retrospectively assessed between January 2016 and February 2017 in two prospective trials that were approved by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contrast Media
Share to DNA Modification Methylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Angiography

Share to Methylation

Share to X-linked Nuclear Protein

Source

Identifiers

PMID: 29468261
DOI: 10.1007/s00062-018-0676-2

Genes

ATRX
IDH1
MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.PMID 29468261Read ↗

Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.Semantic proximity Read ↗

Correlation between dynamic susceptibility contrast perfusion MRI and genomic alterations in glioblastoma.Semantic proximity Read ↗

Association of dynamic susceptibility contrast- and dynamic contrast-enhanced magnetic resonance imaging parameters with molecular marker status in lower-grade gliomas: A retrospective study.Semantic proximity Read ↗

Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.Semantic proximity Read ↗

Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.Semantic proximity Read ↗

The role of DSC MR perfusion in predicting IDH mutation and 1p19q codeletion status in gliomas: meta-analysis and technical considerations.Semantic proximity Read ↗

Advanced imaging of IDH-mutant gliomas: Precision in diagnosis and management.Semantic proximity Read ↗

A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.Semantic proximity Read ↗

Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.Semantic proximity Read ↗

Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.Semantic proximity Read ↗

Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning.Semantic proximity Read ↗

RCBVmax from DSC Perfusion MRI as a Supportive Imaging Biomarker for Differentiating IDH-Mutant Astrocytomas and Oligodendroglioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.